S
Scienture Holdings, Inc. (SCNX)
NCM – Real vaqt narxi. Valyuta: USD
0.40
-0.01 (-1.46%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.40
-0.01 (-1.46%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Scienture Holdings, Inc. Markaziy asab tizimi va yurak-qon tomir kasalliklarini davolash uchun mahsulotlarni ishlab chiqish va tijoratlashtirishga qaratilgan farmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniya gipertenziya, diabetik nefropatiya va gipertenziya hamda chap qorincha gipertrofiyasi bo'lgan bemorlarda insult xavfini kamaytirishni davolash uchun 1-bosqichda bo'lgan losartan kaliyining og'iz orqali qabul qilinadigan suyuq shakli bo'lgan SCN-102 va ko'p dozali dihidroergotamin mesilat (DHE) in'ektsiya ruchkasini ishlab chiqadi. Shuningdek, u tromblardagi fibrin bilan bog'lanadigan va yopishib qolgan plasminogenni plazminga aylantiradigan trombolitik vosita bo'lgan SCN-106 va jarrohlikdan keyingi mahalliy va mintaqaviy analjeziya uchun uzoq muddat ta'sir qiluvchi opioid bo'lmagan og'riq qoldiruvchi vositaning in'ektsion suspenziya shakli bo'lgan SCN-107ni ishlab chiqadi. Scienture Holdings, Inc. Nyu-Yorkning Commack shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Narasimhan Mani M.B.A., Ph.D. | President, Co-CEO & Director |
| Dr. Shankar Hariharan Ph.D. | Founder, Co-CEO & Executive Chairman |
| Mr. Rahul Surana M.B.A., Ph.D. | Executive VP & COO of Scienture LLC |
| Ms. Michele Rath | Senior VP & Chief Commercial Officer of Scienture LLC |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | 8-K | form8-k.htm |
| 2026-05-01 | 8-K | form8-k.htm |
| 2026-04-30 | 10-K/A | form10-ka.htm |
| 2026-03-30 | 10-K | form10-k.htm |
| 2025-11-18 | 8-K | form8-k.htm |
| 2025-11-14 | 8-K | form8-k.htm |
| 2025-11-13 | 8-K | form8-k.htm |
| 2025-11-12 | 10-Q | form10-q.htm |
| 2025-10-30 | 8-K | form8-k.htm |
| 2025-10-24 | 8-K | form8-k.htm |